January 8, 2013

Biotech companies saw a decline in project delays due to regulations over the past year, as more than half have said insurance coverage and reimbursement issues have become more difficult, according to a new report.

January 13, 2011

Various companies in the healthcare industry are uncertain about the benefits of the Food and Drug Administration’s risk evaluation and mitigation strategy program, and most think it needs a major overhaul, according to a study by the Tufts University Center for the Study of Drug Development.

September 21, 2010

The National Institutes of Health has retained ScriptPro as a provider of pharmacy automation systems,...

June 30, 2010

The chain retail pharmacy industry’s main lobby expressed support Thursday for sustainable and safe disposal...

June 21, 2010

The use of surrogate endpoints to help measure efficacy in clinical trials would be of...

June 14, 2010

An investigational drug for treating multiple sclerosis has a shot at becoming a top seller,...

February 23, 2010

The Food and Drug Administration and the National Institutes of Health hope to accelerate the...